Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001721275 | SCV000250596 | likely benign | not provided | 2021-05-13 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV000766104 | SCV000897583 | uncertain significance | X-linked intellectual disability with marfanoid habitus; FG syndrome 1; Blepharophimosis - intellectual disability syndrome, MKB type | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003595887 | SCV002402909 | benign | FG syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354550 | SCV002659944 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003985305 | SCV004757598 | likely benign | MED12-related disorder | 2023-04-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |